Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
3.620
+0.080 (2.26%)
Mar 31, 2025, 2:33 PM EDT - Market open
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $136.34 million as of March 31, 2025. Its market cap has decreased by -52.45% in one year.
Market Cap
136.34M
Enterprise Value
70.48M
1-Year Change
-52.45%
Ranking
Category
Stock Price
$3.62
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $136.34M, a decrease of -72.07%. That is a compound annual growth rate of -29.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 133.33M | -51.50% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |